Neovasc Investor Relations Material
Latest events
Q3 2022
Neovasc
Q4 2022
31 Mar, 2023
Corporate Strategy Update
11 Nov, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Neovasc Inc
Access all reports
Neovasc Inc. is a medical device company that focuses on the development of products for the treatment of cardiovascular diseases. The company's primary offerings include devices designed to address refractory angina, a chronic condition characterized by chest pain, and to support heart valve repair procedures. The company is headquartered in Richmond, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
NVCN
Country
🇨🇦 Canada